Trial Profile
Effects of levosimendan on heart failure markers in patients with chronic decompensated heart failure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2011
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure
- Focus Biomarker; Pharmacodynamics
- 12 Jan 2011 New trial record